| Dr Hankyu Chung, MD | |
|
2039 Forest Ave, Suite 303, San Jose, CA 95128-4817 | |
| (408) 297-8600 | |
| (408) 297-5643 |
| Full Name | Dr Hankyu Chung |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 55 Years |
| Location | 2039 Forest Ave, San Jose, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447367966 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | A31980 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Santa Clara Valley Medical Center | San jose, CA | Hospital |
| Entity Name | Hankyu Chung Md Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780793497 PECOS PAC ID: 1557447919 Enrollment ID: O20080325000639 |
News Archive
Older people who ate fish once or twice a week had a 20 percent lower risk of developing congestive heart failure during 12 years of follow-up, according to a new study (PDF) in the June 21, 2005, issue of the Journal of the American College of Cardiology.
Physicians have a new resource for managing disease in patients with early-stage breast cancer. Patients diagnosed with ductal carcinoma in situ - cancer that has not left the breast ducts - now have the benefit of a multi-gene analysis that considers gene patterns to individualize therapy and determine the chance for recurrence, potentially sparing the patient additional therapy.
When it became apparent in early 2020 just how serious the COVID-19-pandemic was, prioritization among corona patients became an acute issue.
Eisai announced today that the company received a Complete Response Letter from the United States Food and Drug Administration (FDA) regarding the New Drug Application (NDA) of rabeprazole sodium extended-release capsules, 50 mg, an investigational proton pump inhibitor (PPI) under review for the healing and long-term maintenance of healing and symptom resolution of erosive gastroesophageal reflux disease (GERD), and for the treatment of daytime and nighttime heartburn and other symptoms of non-erosive GERD.
Crescendo Biologics Limited today announces it has established a colony of engineered mice completely devoid of endogenous antibody polypeptides. The proprietary 'triple knockout' mice are believed to be unique and have the immunoglobulin heavy chain (IgH), kappa light chain and lambda light chain loci all functionally silenced by large-scale genomic deletion.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Hankyu Chung, MD 2039 Forest Ave, Suite 303, San Jose, CA 95128-4817 Ph: (408) 297-8600 | Dr Hankyu Chung, MD 2039 Forest Ave, Suite 303, San Jose, CA 95128-4817 Ph: (408) 297-8600 |
News Archive
Older people who ate fish once or twice a week had a 20 percent lower risk of developing congestive heart failure during 12 years of follow-up, according to a new study (PDF) in the June 21, 2005, issue of the Journal of the American College of Cardiology.
Physicians have a new resource for managing disease in patients with early-stage breast cancer. Patients diagnosed with ductal carcinoma in situ - cancer that has not left the breast ducts - now have the benefit of a multi-gene analysis that considers gene patterns to individualize therapy and determine the chance for recurrence, potentially sparing the patient additional therapy.
When it became apparent in early 2020 just how serious the COVID-19-pandemic was, prioritization among corona patients became an acute issue.
Eisai announced today that the company received a Complete Response Letter from the United States Food and Drug Administration (FDA) regarding the New Drug Application (NDA) of rabeprazole sodium extended-release capsules, 50 mg, an investigational proton pump inhibitor (PPI) under review for the healing and long-term maintenance of healing and symptom resolution of erosive gastroesophageal reflux disease (GERD), and for the treatment of daytime and nighttime heartburn and other symptoms of non-erosive GERD.
Crescendo Biologics Limited today announces it has established a colony of engineered mice completely devoid of endogenous antibody polypeptides. The proprietary 'triple knockout' mice are believed to be unique and have the immunoglobulin heavy chain (IgH), kappa light chain and lambda light chain loci all functionally silenced by large-scale genomic deletion.
› Verified 9 days ago
Dr. Arunasri Kelleti, M.D., Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 1333 Meridian Ave, San Jose, CA 95125 Phone: 408-445-3400 | |
Assefa Worku, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 250 Hospital Pkwy, 260 International Circle, San Jose, CA 95119 Phone: 408-972-7000 Fax: 408-363-4906 | |
Dr. John J Redinski, DO Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 225 N Jackson Ave, San Jose, CA 95116 Phone: 408-347-4051 | |
Jenny Liu, D.O. Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 751 S. Bascom Ave., San Jose, CA 95128 Phone: 408-885-5000 | |
Dr. Komal J Bhatt, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 225 N Jackson Ave, San Jose, CA 95116 Phone: 408-259-5000 | |
Dr. Alexander D Doan, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 105 N Bascom Ave, #103, San Jose, CA 95128 Phone: 408-998-2890 Fax: 408-998-2897 | |
Eamonn Patrick Dunphy, MD Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 751 S Bascom Ave, Radiation Oncology, San Jose, CA 95128 Phone: 408-885-4150 |